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Background: The use of  illicit drugs has become a worldwide health problem. Substances with the potential to be abused may 
have direct or indirect effects on physiologic mechanisms that lead to organ system dysfunction and diseases.
Objective: The present study aims to investigate the structural and reabsorption integrity of  the nephron among Egyptian ad-
dicts of  tramadol alone and coabused with cannabis.
Methods: Sixty-five males were included in the study, they were classified into control group (G1=19), tramadol addicts group 
(G2=18), and tramadol coabused with cannabis addicts group (G3=28). Parameters investigated for structural integrity were 
urinary levels ofleucineaminopeptidase and N-acetyl-β-D-glucosaminidase, and urinary parameters for reabsorption integrity 
were levels of  copper and zinc as well as calcium, also urinary creatinine was measured. In addition, urinary levels of  tramadol 
and tetrahydrocannabinol were estimated.
Results: Among the two addicted groups, all measured parameters were not significantly different in comparison with the con-
trol group except for urinary calcium excretion which was found to be significantly increased among the two addicted groups.
Conclusion: Both tramadol addiction alone or coabused with cannabis causes increased urinary excretion of  calcium, indicating 
reabsorption dysfunction of  calcium without affecting structural integrity along the nephron.
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Introduction
The use of  illicit drugs has become a worldwide health 
problem. It leads to numerous consequences at the 
health, economic, social and legal levels. These conse-
quences interfere with the development of  the countries 
and their efforts to respond to the needs of  their popu-
lations. Apart from its economic cost, drug abuse leads 
to social problems among family members, abnormal be-
havior, crime, health and psychological problems as well 
as economic difficulties1.
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Tramadol (Tr) is a synthetic opioid from the aminocyclo-
hexanol group and is commonly used in clinical practice 
as analgesic for treatment of  moderate to severe pain2. 
Tramadol is free of  side effects of  traditional opioid such 
as the risk for respiratory depression3 and drug depen-
dence4. So, the abuse potential of  tramadol is considered 
low or absent5, which is in contrast to other opioids.
Cannabis was used a long time ago for both recreational 
and medicinal purposes. The plant Cannabis sativa (In-
dian hemp) is the source of  different psychoactive prod-
ucts. Marijuana comes from leaves, stems, and dried flow-
er buds of  the plant. Hashish is a resin obtained from 
flowering buds of  the hemp plant6. ∆9-tetrahydrocannab-
inol (∆9-THC) is the primary psychoactive compound 
and contributes to the behavioral toxicity ofcannabis7.
Calcium (Ca) is the most abundant divalent ion (Ca2+) in 
the body8. Calcium is reabsorbed along all segments of  
the nephron. The proximal tubule is the primary tubular 
segment where most of  the filtered calcium is reabsorbed. 
Under normal condition, 98-99% of  the calcium which 
passes into the tubule is reabsorbed. Approximately 60-
70% of  the filtered calcium is reabsorbed in the proximal 
convoluted tubule, 20% in the loop of  Henle, 10% by the 
distal convoluted tubule, and 5% by the collecting duct9. 
Any calcium that is not reabsorbed then passes into what 
is now urine and into the bladder.
Copper(Cu) is important for all functions of  many cellular 
enzymes10. The copper transporters ATP7A and ATP7B 
are expressed at distinct regions of  the kidney11. They are 
both expressed in the glomeruli in minor amounts. AT-
P7A is localized in the proximal and distal tubules, while 
ATP7B is expressed in the loop of  Henle. The two cop-
per transporters work together to maintain copper bal-
ance within this tissue. The ability of  ATP7A to traffic to 
basolateral membrane (an event associated with copper 
export) in response to copper elevation strongly suggests 
that ATP7A plays the major role in exporting copper 
from renal cells for reabsorption into the blood and in 
protecting renal cells against copper overload12. In an-
other research, ATP7B expression in the loops of  Henle 
suggests that once in the filtrate, ATP7B is responsible 
for copper reabsorption11. Previous data suggest that 
copper may be reabsorbed by the same pathway as that 
involved in iron reabsorption13, which occurs between the 
proximal and distal convoluted tubules, interpreted as the 
loops of  Henle.
Zinc (Zn) exists as a divalent cation (Zn2+). The kid-
ney epithelium is the site of  urinary zinc excretion and 
reabsorption. Zinc reabsorption occurs in all the down-
stream segments of  the nephron; proximal tubule, Loop 
of  Henle, and terminal nephron segments14. Most of  the 
filtered Zn is reabsorbed along kidney proximal tubule15.
The kidney is considered the primary eliminator of  exog-
enous drugs and toxins; impairment of  excretion predis-
poses it to various forms of  injury. Development of  new 
biomarkers is needed for the specific diagnosis of  nephro-
toxicity at earlier stage16. These biomarkers include brush 
bodrder enzyme such as Leucineaminopeptidase (LAP)17, 
Lysosomal enzyme such as N-acetyl-β-D-glucosamini-
dase (NAG)18, and cytosolic enzyme such as α- glutathion 
S-transferase (α-GST)18. Thus, detection of  enzymes in 
the urine potentially provides valuable information not 
only related to the site of  tubular injury (proximal & dis-
tal tubule) but also to the severity of  injury16.
 
Renal tubular cells, in particular proximal tubule cells, 
are vulnerable to the toxic effects of  drugs because their 
role in concentrating and reabsorbing glomerular filtrate 
exposes them to high levels of  circulating toxins19. Al-
though most nephrotoxicity occurs in the proximal part 
of  the nephron, some chemicals damage distal tubules. 
The function of  these structures facilitates their vulnera-
bility to toxicants20.
Drug addiction has been associated with various forms 
of  renal diseases which may be related to direct effect of  
the drugs themselves while others are caused by compli-
cations related to drug abuse21.
The present work aims to investigate the effect of  tra-
madol addiction on urinary excretion of  some metals 
(e.g. copper, zinc and calcium) in relation to structural 
integrity of  proximal tubules which were evaluated by 
measuring the urinary excretion of  proximal tubular spe-
cific enzymes e.g. LAP and NAG. In addition, the study 
was extended to evaluate the effect of  tramadol addiction 
coabused with cannabis.
Materials & methods
The study was designed to be a comparative cross-sec-
tional one from December 2015 to March 2016. Par-
ticipants in the present investigation were recruited on 
voluntary bases from non-smoking males attending the 
outpatient clinic, El-Demerdash hospital, Ain-Shams 
University, for treatment of  drug addiction. All partici-
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pates were subjected to interview using a questionnaire 
designed to obtain information about previous medical 
and occupational history, medication intake, actual health 
status, and subjective symptoms. All subjects underwent a 
routine clinical examination and a routine urinalysis. The 
interview and clinical examination were performed by the 
clinic physicians under the supervision of  one of  the au-
thors. Participants of  the control group were recruited 
from relatives of  the addicted participants after apply-
ing the same exclusion criteria and clinical examination. 
A participant was excluded from the present study if  he 
had:
1. A history of  disease affecting the kidney before onset 
of  addiction or any disease likely to impair renal function 
or affect the urinary excretion of  the investigated param-
eters e.g. (diabetes mellitus, hypertension, collagen diseas-
es as systemic lupus erythromatosis, Urinary tract disease, 
Rheumatoid arthritis and gout.
2. A previous or present exposure to agents capable of  
damaging the kidney, heavy metals such as lead (Pb2+) 
and cadmium (Cd2+) as well as other nephrotoxins such 
as organic solvents.
3. Regular and prolonged treatment by drugs affecting 
the kidney e.g. aminoglycosides and antirheumatic drugs.
4. Dental mercury amalgam filling as it may affect the 
kidney.
5.  Cigarette smoker.
 
A total of  sixty-five males were included in the present 
study and divided into three groups as follows: Control 
group (G1) was comprised of  19 males, Tramadol addicts 
(G2) were comprised of  18 males, Tramadol coabused 
with cannabis addicts (G3) was comprised of  28 males.
Sampling
Before starting treatment from addiction, morning urine 
sample was collected from each participant into 100 ml 
sterilized plastic container and centrifuged at 4500 rpm 
for 5 minutes, and then the clear supernatant was distrib-
uted in polyethylene vials (1.5 ml capacity).  One vial was 
used on the same day of  urine collection for measuring 
tramadol (Tr) and cannabis in urine, the rest of  vials were 
stored at-20°C without preservatives until analyzed with-
in 2 weeks.
Methods
Each urine sample was analyzed for the determination of:
1. Urinary tramadol (U.Tr) concentration by immunaly-
sis using immunalysis EIA kit (immunalysis corporation, 
USA).
2. Urinary ∆9-THC concentration by DRI® cannabinoid 
assay (Microgenics, USA).
3. Urinary NAG and LAP concentration for the assess-
ment of  proximal tubular structural integrity by colori-
metric method using NAG kit (Diazymelaboratotries, 
USA) and LAP kit (Randox, UK).
4. Urinary Cu,Zn, and Ca concentration for assessment 
of  reabsorption integrity of  the proximal tubules by 
Thermo Scientific ICE 3000 Series Atomic Absorption 
Spectrophotometer, England.
5. Urinary creatinine (U. Cr) concentration by Jaffe kinetic 
method using kit (Greiner Diagnostic GmbH, Germany).
Statistical analysis
Data was tabulated as mean ± SD. ANOVA was used to 
compare between more than two means of  independent 
groups. In case of  parametric data, if  ANOVA was sta-
tistically significant, Post Hoc test was used to compare 
between each two means, while Mann- Whitney and Kru-
skall-Wallis tests were used for non-parametric data. Cor-
relation coefficient was calculated to examine the relation 
between investigated urinary parameters. Results were 
considered statistically significant at P < 0.05.
Results and discussion
Regarding age, results of  the present study (Table 1) 
showed that the three  investigated groups were of  com-
parable age since there was insignificant difference be-
tween G1 and each of  G2 (P1 > 0.05) and G3(P2 > 0.05) 
as well as between G2 and G3 (P3 > 0.05), suggesting that 
age has no effect on the investigated urinary parameters.
Concerning the investigated urinary enzymes of  structur-
al integrity of  the proximal tubules (U.NAG/U.Cr and 
U.LAP/ U.Cr), data in (Table 1) demonstrated insignif-
icant difference between the three investigated groups, 
suggesting that tramadol did not cause a damaging effect 
on the structural integrity of  the proximal tubules, and 
even coabuse of  cannabis with tramadol addiction has no 
effect on the structural integrity of  the proximal tubules. 
This suggests that neither tramadol addiction alone nor 
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tramadol coabused with cannabis affects the structural 
integrity of  the proximal tubules among the investigated 
addicted individuals in the present study. These findings 
support the results reported by others22.
Regarding the effect of  addiction on reabsorption integ-
rity of  the nephron for U.Cu/U.Cr and U.Zn/U.Cr as 
well as U.Ca/U.Cr, results in (Table 1) showed insignifi-
cant changes (P2 > 0.05) in urinary excretion of  U.Cu/U.
Cr and U.Zn/U.Cr among the three investigated groups, 
suggesting also that neither tramadol addiction alone 
nor coabused with cannabis could affect the reabsorp-
tion integrity of  the nephron for both Cu and Zn.Also, 
this suggests that cannabis itself  has no effect on the re-
absorption integrity of  the nephron for U.Cu/U.Cr and 
U.Zn/U.Cr. 
Table 1: Data (Mean ± SD) of investigated parameters 
among different studied groups: 
  
    
   
parameters 
   
G1 (n=1
9) 
   
G2 (
n= 18) 
   
G3 (
n= 28) 
   
P 
Age (Years) 23.79 ± 3.91 28.78 ± 6.76 26.82 ± 5.45 P > 0.05 
Addiction Duration ---- 3.97 ± 3.97 7.79 ± 4.70 P > 0.05 
(Years)         
U.Tr/U.Cr     (mg/gm) ---- 2629.92 ± 5381.81 1394.61 ± 2951.20 P > 0.05 
U.THC/U.Cr (mg/gm) ---- ---- 0.18 ± 0.22 P > 0.05 
                      N: Number of individuals participated in each investigated group. 
  
On comparing the three investigated groups using ANOVA, (Table 1) revealed a significant increase 
(P < 0.05) in the urinary excretion of calcium and insignificant differences regarding all others 
investigated parameters. 
Concerning the effect of  addiction on urinary excretion 
of  U.Ca/U.Cr, results in (Table 2) revealed a significant 
increase in U.Ca/U.Cr excretion among tramadol addict-
ed group (G2) (P1 < 0.05) whencompared with (G1), 
suggesting that tramadol addiction causes reabsorption 
impairment of  the nephron function regarding urinary 
calcium. This finding and suggestion receive support 
from the report that opioids cause increased levels of  
growth hormone and vasopressin23. 
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It was reported that growth hormone excess such as oc-
curs in acromegaly causes hypercalciuria which appears 
to be a tubular effect and that vasopressin may increase 
calciumexcretion due to its effect on reducing calcium 
transport the thick ascending limb24. Furthermore, (Table 
2) showed a significant increase in U.Ca/U.Cr excretion 
among tramadol coabused with cannabis group (G3) (P2 
< 0.05) when compared with (G1), and this excretion was 
also significantly increased more than the one in trama-
dol addicted group (G2) on comparison between (G3) 
and (G2), suggesting that cannabis may have a synerget-
ic effect to the impairment effect of  tramadol on reab-
sorption of  calcium along the nephron. This suggestion 
is supported by results in (Table 2) which demonstrated 
a significant increase in U.Ca/U.Cr excretion intramadol 
coabused with cannabis group (G3) (P2 < 0.05) when 
compared with tramadol addicted group (G2), and the 
finding of  a significant correlation (r = 0.5, P2 < 0.01) be-
tween U.Ca/U.Cr and U.THC/U.Cr levels in (G3) (Table 
4). Moreover, other investigators25 reported mild kidney 
function decline among patients who had used marijua-
na, and others reported that tramadol has negative im-
pacts on kidney function in human26 and experimental 
animals27 as evidenced by an increase in BUN and serum 
creatinine levels. Other studies reached similar results28,29.
Results of  the present study (Table 1) showed that the 
two addicted groups were having different addiction du-
ration, and since the addiction duration in G3 is longer 
than in G2, it  could be suggested that the abuser had 
started addiction with only one drug and after a period 
of  time (that is with increasing age) the abuser started the 
coabuse of  the second drug. This suggestion is supported 
by the report of  others30 who found that for the cases of  
tramadol abuse, 97% of  the drug addicts used tramadol 
in combination with other drugs or they had a previous 
history of  addiction to substance of  abuse. In addition, 
results in (Table 4) revealed a significant correlation (r = 
0.552, P < 0.01) between age and addiction duration in 
G3, thus adding more support to the above suggestion.
Table 2: Comparison between different investigated groups 
regarding urinary calcium excretion 
  




G1     Control group (N= 19) 
  
Mean ± SD                                                                  39.41 ± 12.19 
  
G2     Tramadol addicts group (N= 18) 
  
Mean ± SD P1 
  




G3     Tramadol coabused with cannabis group (N= 28) 
   
Mean ± SD P2 
                                                                                              P3 






   
N: Number of individuals participated in each investigated group, 
  
P1: G2 compared with G1, P2: G3 compared with G1, P3: G3 compared with G2. 
  
In addition, (Table 2) demonstrated a significant difference (P < 0.05) in the urinary 
calcium excretion in each of the two addicted groups (G2and G3) on comparing each of them with 
the control group (G1), as well as on comparing both of them together. 
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Table 3: Correlation coefficient (r) between investigated parameters 
in the tramadol addicted group: 
 
Age    Addiction                                                               Urinary parameters 
  
  duration U.Tr/U. 
Cr 
U.NAG/U.Cr U.LAP/U.Cr U.Cu/U.Cr U.Zn/U.Cr U.Ca/U.Cr 
  mg/gm U/gm U/gm μg/mg μg/mg μg/mg 
Age 1 0.260 -0.004 0.016 -0.223 0.009 0.027 0.001 






















U.NAG/U.Cr      1 0.298 0.119 0.150 0.635** 
U.LAP/U.Cr         1 0.442 0.769** 0.519* 
U.Cu/U.Cr           1 0.488* 0.174 
U.Zn/U.Cr             1 0.298 
U.Ca/U.Cr               1 
 
   
*r is significant as (P < 0.05) ** r is highly significant as (P < 0.01). 
  
Results of the present work (Table 3) revealed a significant positive correlation between U.LAP/U.Cr 
and each of U.Zn/U.Cr and U.Ca/U.Cr, and also between U.Cu/U.Cr and U.Zn/U.Cr, as well as between 
U.NAG/U.Cr and U.Ca/U.Cr. 
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Table 4: Correlation coefficient (r) between investigated parameters in the tramadol 
coabused with cannabis addicted group: 
  
  
Age Addiction    Urinary parameters  





Cr     
 
  U.Cu/U.Cr U.Zn/U.Cr U.Ca/U.Cr 






Addiction   1 0.002 -0.126 -0.207 -0.211 -0.072 -0.144 0.039 
Addicti
on 






























      -0.149           -0.189          -0.011      -0.033        -0.152  
 


























































*r is significant as (P < 0.05) ** r is highly significant as (P < 0.01). 
  
Data from the (Table 4) demonstrate a positive correlation between age and addiction duration, and between 
U.THC/U.Cr and each of U.LAP/U.Cr, U.Cu/U.Cr, U.Zn/U.Cr and U.Ca/U.Cr, as well as between U.NAG/U.Cr 
and U.LAP/U.Cr, also between U.LAP/U.Cr and each of U.Cu/U.Cr, U.Zn/U.Cr and U.Ca/U.Cr, as well as between 




   


























































*r is significant as (P < 0.05) ** r is highly significant as (P < 0.01). 
  
Data from the (Table 4) demonstrate a positive correlation betwe n age nd d iction duration, and betwe n 
U.THC/U. r and each of U.LAP/U.Cr, U.Cu/U.Cr, U.Zn/U.Cr and U.Ca/U.Cr, as well as betwe n U.NAG/U.Cr 
and U.LAP/U.Cr, also betwe n U.LAP/U.Cr and each of U.Cu/U.Cr, U.Zn/U.Cr and U.Ca/U.Cr, as well as betwe n 




   


























































*r is significant as (P < 0.05) ** r is highly significant as (P < 0.01). 
  
Data from the (Table 4) demonstrate a positive correlation between age and addiction duration, and between 
U.THC/U.Cr and each of U.LAP/U.Cr, U.Cu/U.Cr, U.Zn/U.Cr and U.Ca/U.Cr, as well as between U.NAG/U.Cr 
and U.LAP/U.Cr, also between U.LAP/U.Cr and each of U.Cu/U.Cr, U.Zn/U.Cr and U.Ca/U.Cr, as well as between 




   
Limitation of  the study
Absence of  cannabis addicted group and the small num-
ber of  recruited participants are the limitations in the 
present study.
Conclusion
Among the investigated addicted individuals, neither the 
addiction of  tramadol alone nor in combination with 
cannabis was found to affect the structural integrity of  
proximal tubules. Moreover, reabsorption integrity of  the 
nephron is affected only with respect to calcium reab-
sorption and not with respect to copper and zinc reab-
sorption. Also, to the best of  our knowledge, this is the 
first study that investigated the effect of  addiction of  tra-
madol alone or coabused with cannabis on the reabsorp-
tion integrity of  the nephron regarding urinary excretion 
of  copper and zinc as well as calcium.
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